Pfizer starts phase-III clinical trial in adults for investigational vaccine against RSV
First subjects vaccinated in study of Pfizer’s RSV bivalent prefusion F subunit investigational vaccine candidate in adults aged…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.